USANA HEALTH SCIENCES, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
USANA HEALTH SCIENCES, INC. (USNA) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $292.00 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-05-09
- USANA HEALTH SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $292.00M, a 14.36% increase year-over-year.
- USANA HEALTH SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-30 was $273.11M, a 7.99% increase year-over-year.
- USANA HEALTH SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $261.76M, a 2.97% increase year-over-year.
- USANA HEALTH SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-07-01 was $257.06M, a 0.56% decline year-over-year.
- USANA HEALTH SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $1.05B, a 4.09% increase from fiscal 2016.
- USANA HEALTH SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $1.01B, a 9.54% increase from fiscal 2016.
- USANA HEALTH SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $918.50M, a 16.20% increase from fiscal 2015.
- USANA HEALTH SCIENCES, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $790.47M, a 10.07% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $292.00M 10-Q · filed 2018-05-09 | $565.11M derived: sum of 2 quarters · filed 2018-05-09 | $826.88M derived: sum of 3 quarters · filed 2018-05-09 | $1.08B derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-30 | $273.11M 10-K · filed 2018-02-28 | $534.88M derived: sum of 2 quarters · filed 2018-02-28 | $791.94M derived: sum of 3 quarters · filed 2018-02-28 | $1.05B 10-K · filed 2018-02-28 |
| 2017-09-30 | $261.76M 10-K · filed 2018-02-28 | $518.83M derived: sum of 2 quarters · filed 2018-02-28 | $774.15M 10-Q · filed 2017-11-08 | $1.03B derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-07-01 | $257.06M 10-K · filed 2018-02-28 | $512.39M 10-Q · filed 2017-08-09 | $765.29M derived: sum of 3 quarters · filed 2018-05-09 | $1.02B derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-04-01 | $255.32M 10-Q · filed 2018-05-09 | $508.22M derived: sum of 2 quarters · filed 2018-05-09 | $762.44M derived: sum of 3 quarters · filed 2018-05-09 | $1.02B derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $252.90M 10-K · filed 2018-02-28 | $507.12M derived: sum of 2 quarters · filed 2018-02-28 | $765.63M derived: sum of 3 quarters · filed 2018-02-28 | $1.01B 10-K · filed 2018-02-28 |
| 2016-10-01 | $254.22M 10-K · filed 2018-02-28 | $512.73M derived: sum of 2 quarters · filed 2018-02-28 | $753.18M 10-Q · filed 2017-11-08 | $985.77M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-07-02 | $258.51M 10-K · filed 2018-02-28 | $498.96M 10-Q · filed 2017-08-09 | $731.55M derived: sum of 3 quarters · filed 2018-02-28 | $964.84M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-04-02 | $240.45M 10-K · filed 2018-02-28 | $473.03M derived: sum of 2 quarters · filed 2018-02-28 | $706.33M derived: sum of 3 quarters · filed 2018-02-28 | $939.57M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-01-02 | $232.59M 10-K · filed 2017-03-01 | $465.88M derived: sum of 2 quarters · filed 2017-03-01 | $699.12M derived: sum of 3 quarters · filed 2017-03-01 | $918.50M 10-K · filed 2018-02-28 |
| 2015-10-03 | $233.29M 10-K · filed 2017-03-01 | $466.54M derived: sum of 2 quarters · filed 2017-03-01 | $685.91M 10-Q · filed 2016-11-09 | $913.78M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | $233.24M 10-K · filed 2017-03-01 | $452.62M 10-Q · filed 2016-08-09 | $680.49M derived: sum of 3 quarters · filed 2017-03-01 | $872.44M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | $219.38M 10-K · filed 2017-03-01 | $447.25M derived: sum of 2 quarters · filed 2017-03-01 | $639.19M derived: sum of 3 quarters · filed 2017-03-01 | $827.45M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | $227.87M 10-K · filed 2016-03-01 | $419.81M derived: sum of 2 quarters · filed 2016-03-01 | $608.07M derived: sum of 3 quarters · filed 2016-03-01 | $790.47M 10-K · filed 2017-03-01 |
| 2014-09-27 | $191.94M 10-K · filed 2016-03-01 | $380.20M derived: sum of 2 quarters · filed 2016-03-01 | $562.60M 10-Q · filed 2015-11-12 | $748.87M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-28 | $188.26M 10-K · filed 2016-03-01 | $370.66M 10-Q · filed 2015-08-12 | $556.92M derived: sum of 3 quarters · filed 2016-03-01 | $730.61M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-03-29 | $182.40M 10-K · filed 2016-03-01 | $368.67M derived: sum of 2 quarters · filed 2016-03-01 | $542.36M derived: sum of 3 quarters · filed 2016-03-01 | $731.49M derived: sum of 4 quarters · filed 2016-03-01 |
| 2013-12-28 | $186.27M 10-K · filed 2015-03-17 | $359.96M derived: sum of 2 quarters · filed 2015-03-17 | $549.09M derived: sum of 3 quarters · filed 2015-03-17 | $718.17M 10-K · filed 2016-03-01 |
| 2013-09-28 | $173.69M 10-K · filed 2015-03-17 | $362.83M derived: sum of 2 quarters · filed 2015-03-17 | $531.91M 10-Q · filed 2014-11-06 | $700.44M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-06-29 | $189.14M 10-K · filed 2015-03-17 | $358.22M 10-Q · filed 2014-08-05 | $526.75M derived: sum of 3 quarters · filed 2015-03-17 | $691.92M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-03-30 | $169.08M 10-K · filed 2015-03-17 | $337.61M derived: sum of 2 quarters · filed 2015-03-17 | $502.79M derived: sum of 3 quarters · filed 2015-03-17 | $663.69M derived: sum of 4 quarters · filed 2015-03-17 |
| 2012-12-29 | $168.53M 10-K · filed 2014-03-13 | $333.70M derived: sum of 2 quarters · filed 2014-03-13 | $494.61M derived: sum of 3 quarters · filed 2014-03-13 | $648.73M 10-K · filed 2015-03-17 |
| 2012-09-29 | $165.18M 10-K · filed 2014-03-13 | $326.08M derived: sum of 2 quarters · filed 2014-03-13 | $480.20M 10-Q · filed 2013-11-07 | $626.14M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $160.90M 10-K · filed 2014-03-13 | $315.02M 10-Q · filed 2013-08-08 | $460.97M derived: sum of 3 quarters · filed 2014-03-13 | $604.47M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $154.12M 10-K · filed 2014-03-13 | $300.07M derived: sum of 2 quarters · filed 2014-03-13 | $443.57M derived: sum of 3 quarters · filed 2014-03-13 | $592.49M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $145.95M 10-K · filed 2013-03-11 | $289.45M derived: sum of 2 quarters · filed 2013-03-11 | $438.37M derived: sum of 3 quarters · filed 2013-03-11 | $581.94M 10-K · filed 2014-03-13 |
| 2011-10-01 | $143.50M 10-K · filed 2013-03-11 | $292.43M derived: sum of 2 quarters · filed 2013-03-11 | $435.99M 10-Q · filed 2012-11-07 | $573.53M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-07-02 | $148.93M 10-K · filed 2013-03-11 | $292.49M 10-Q · filed 2012-08-08 | $430.03M derived: sum of 3 quarters · filed 2013-03-11 | $565.04M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-04-02 | $143.57M 10-K · filed 2013-03-11 | $281.11M derived: sum of 2 quarters · filed 2013-03-11 | $416.11M derived: sum of 3 quarters · filed 2013-03-11 | $542.12M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-01-01 | $137.54M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $272.55M derived: sum of 2 quarters · filed 2013-03-11 | $398.56M derived: sum of 3 quarters · filed 2013-03-11 | $517.64M 10-K · filed 2013-03-11 |
| 2010-10-02 | $135.01M 10-Q · filed 2011-11-09 | $261.02M derived: sum of 2 quarters · filed 2011-11-09 | $380.10M 10-Q · filed 2011-11-09 | |
| 2010-07-03 | $126.01M 10-Q · filed 2011-08-10 | $245.10M 10-Q · filed 2011-08-10 | ||
| 2010-01-02 | $436.94M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |